PDF
(Download)
|
- Black Cohosh (Actaea racemosa syn. Cimicifuga racemosa)
- Stress
- Anxiolytic Effects
|
Date:
01-31-2013 | HC# 091264-465
|
Re: Black Cohosh Reduces Physiological and Psychological Stress Responses
Nadaoka
I, Yasue M, Sami M, Kitagawa Y, Koga Y. Oral administration of Cimicifuga racemosa extract attenuates
psychological and physiological stress responses. Biomed Res. June 2012;33(3):145-152.
Black
cohosh (BC; Actaea racemosa syn. Cimicifuga racemosa) dietary supplements
are most commonly used to reduce negative menopausal symptoms. In Native
American traditional medicine, BC was used as a tonic, analgesic, and fatigue
treatment, in addition to its prevalent usage in childbirth and the treatment
of menstrual problems. Pharmacological studies have confirmed that BC exerts
dopaminergic and serotonergic effects, rather than estrogen-like activities. In
vitro, BC is an agonist of serotonin receptors, a competitive ligand and partial
agonist of opiate receptors, and a positive modulator of gamma-aminobutyric
acid (GABA) receptors. In vivo, BC has also been shown to attenuate the hypothalamic-pituitary-adrenal
axis (HPA axis) stress response by decreasing corticosterone levels and modulating
the sympathetic adrenomedullary (SAM) system stress-induced changes in dopamine
(DA), serotonin (5-hydroxytryptamine [5-HT]), and norepinephrine (NE) metabolism.
However, the anxiolytic effects of BC have not been evaluated in humans. This
randomized, double-blind, placebo-controlled, crossover trial investigated the
effects of BC on stress via the measurement of chromogranin-A (CgA; a protein
used as a stress marker), cortisol, perceived stress intensity, and brainwave
patterns.
This
study consisted of 2 experiments with healthy adults. Twenty men (n=20) were
enrolled in experiment 1, while both men (n=6) and women (n=5) were enrolled in
experiment 2 (n=11). All subjects were free from a history of or current mental
illness and drug use. They were instructed to continue normal sleep and other general
routines, and to refrain from heavy physical exercise, tobacco use, and stimulant
consumption (e.g., alcohol, caffeine, etc.) the day prior to each test.
Subjects were randomized to receive either 200 mg/day of encapsulated BC
extract (supplied by Nippon Funmatsu Yakuhin; Osaka, Japan) or identical placebo
capsules containing 200 mg of lactose. [Note: No information on the extract
preparation, concentration, or standardization was given.] Statistical
significance was designated at P-values <0.05.
The
first experiment consisted of 2 test sessions conducted a week apart. On the
test day, baseline psychological measurements and saliva samples were collected
before the subjects took the study medication. One hour following ingestion,
the Uchida-Kraepelin (U-K) test, a math-related questionnaire testing for speed
and accuracy, was administered in such a way as to impede subjects' successful
completion. At the end of the U-K test (time 0) and 60 minutes later, saliva
and psychological parameters were again assessed. The procedure was repeated 1
week later with the subjects taking the alternate medication.
The
psychological measures were a visual analog scale (VAS) of perceived stress intensity
and the State-Trait Anxiety Inventory (STAI). With the BC treatment, the mean
VAS score was significantly lower at time 0 compared to placebo (P<0.01). No
significant differences in the STAI scores were observed.
The
saliva samples were analyzed to determine the concentration of the
physiological stress markers CgA and cortisol. CgA is an indicator of the
stress response mediated by the SAM system, while cortisol is an indicator of
the response mediated by the HPA axis.
The
BC treatment attenuated the SAM system-mediated stress response, significantly
lowering CgA concentrations midway through the U-K test (P=0.05), at time 0
(P=0.01), and 60 minutes after completing the test (P<0.05). No significant
differences were seen in cortisol concentrations.
In
experiment 2, a modified U-K test requiring oral answers was conducted 60
minutes after ingestion of the study medication. Electroencephalography
(EEG) was used to measure alpha waveband brain activity prior to the U-K test
(baseline), mid-test, at time 0 (end of test), and 60 minutes after the test.
The test was repeated 7 days later with subjects taking the alternate
treatment.
The
left and right occipital EEG data was analyzed for temporal variations in the
alpha waveband. A recovery trend was observed from time 0 to 60 minutes after
the test but the differences were not statistically significant (P=0.06 and P=0.07,
respectively).
In
summary, BC significantly reduced the VAS measure of psychological stress but
not the STAI. It significantly reduced the concentration of the SAM system stress
response indicator, CgA, but did not affect the concentration of the HPA axis
stress response indicator, cortisol. In light of the in vitro and in vivo data
and the limitations of this study, the authors maintain that BC affects both the
HPA axis and SAM system stress responses and they suggest that BC may be
suitable for the prevention and treatment of stress-related disorders.
This
study suffers from a few major problems. The results cannot be generalized to
other BC extracts nor can other researchers repeat the experiments because no information
regarding the BC extract preparation, concentration, or standardization is
provided. Inclusion criteria are not described and exclusion criteria are limited.
The testing was done in the morning, when cortisol levels are high – a flaw in
the study design. In this case, the salivary CgA would have been a better
indicator of psychological stress. It reflects psychological stress more
rapidly and is considered more sensitive than cortisol. The sample size was
also very small. Nonetheless, the balance of the evidence indicates that
further studies of BC's anxiolytic mechanism of action and clinical efficacy
are warranted.
—Amy C. Keller, PhD
Editorial Comment: It is interesting to note that the extant
experimental and clinical evidence supports the Native American traditional use
of BC as a tonic and treatment of fatigue.
|